Towards an understanding of psychedelic-induced neuroplasticity

This review (2022) investigates how classical psychedelics (LSD, psilocybin, ayahuasca) elicit neuroplasticity. Animal and human studies show evidence for neuroplasticity, but evidence for BDNF (protein, encoded by a gene, indicated in neuronal growth) is mixed in humans. Neuroplasticity mostly happens through the 5-HT2a receptor (but other serotonin receptors could also be involved). Most of this happens 5-HT2a rich areas in the brain (neocortex). The evidence for micro/mini-dosing on neuroplasticity is currently inconclusive. Neuroplasticity happens as fast as in a few hours, lasting up to a month.

Abstract

“Classic psychedelics, such as LSD, psilocybin, and the DMT-containing beverage ayahuasca, show some potential to treat depression, anxiety, and addiction. Importantly, clinical improvements can last for months or years after treatment. It has been theorized that these long-term improvements arise because psychedelics rapidly and lastingly stimulate neuroplasticity. The focus of this review is on answering specific questions about the effects of psychedelics on neuroplasticity. Firstly, we review the evidence that psychedelics promote neuroplasticity and examine the cellular and molecular mechanisms behind the effects of different psychedelics on different aspects of neuroplasticity, including dendritogenesis, synaptogenesis, neurogenesis, and expression of plasticity-related genes (e.g., brain-derived neurotrophic factor and immediate early genes). We then examine where in the brain psychedelics promote neuroplasticity, particularly discussing the prefrontal cortex and hippocampus. We also examine what doses are required to produce this effect (e.g., hallucinogenic doses vs. “microdoses”), and how long purported changes in neuroplasticity last. Finally, we discuss the likely consequences of psychedelics’ effects on neuroplasticity for both patients and healthy people, and we identify important research questions that would further scientific understanding of psychedelics’ effects on neuroplasticity and its potential clinical applications.”

Authors: Abigail E. Calder & Gregor Hasler

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account

Find this paper

Towards an understanding of psychedelic-induced neuroplasticity

https://doi.org/10.1038/s41386-022-01389-z

Open Access | Google Scholar | Backup | 🕊

Published in
Neuropsychopharmacology
September 19, 2022
0 citations

Study details

Topics studied
Neuroscience

Study characteristics
Literature Review

0 Comments
Inline Feedbacks
View all comments